You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

YKL-40 C

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Erectile Dysfunction, Erectile Dysfunction With Diabetes Trial in Aswan (Tadalafil 5mg)

Completed
  • Erectile Dysfunction
  • Erectile Dysfunction With Diabetes Mellitus
  • Tadalafil 5mg
  • Aswan, Egypt
    Aswan university
Jul 5, 2022

YKL -40 as New Biomarker in COVID -19 Patients

Not yet recruiting
  • COVID-19
  • Computerized Tomography
  • (no location specified)
Nov 25, 2021

Acne Vulgaris Trial in Aswan (Isotretinoin)

Active, not recruiting
  • Acne Vulgaris
  • Aswan, Egypt
    Aswan university
Sep 1, 2022

To Evaluate the Clearance Rate of Uremic Toxin by HFR Trial (HFR)

Not yet recruiting
  • To Evaluate the Clearance Rate of Uremic Toxin by HFR
  • HFR
  • (no location specified)
Aug 15, 2023

Mild Cognitive Impairment Trial in Baltimore (A: 40 Hz music, B: 40 Hz sound, C: Preferred music)

Recruiting
  • Mild Cognitive Impairment
  • A: 40 Hz music
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins School of Nursing
Dec 6, 2022

Bladder Cancer Trial in Goyang (intravesical mitomycin-C 40mg/20ml instillation)

Completed
  • Bladder Cancer
  • intravesical mitomycin-C 40mg/20ml instillation
  • Goyang, Korea, Republic of
    National Cancer Center
Jan 30, 2023

Type2 Diabetes Trial (vitamin D, vitamin D )

Enrolling by invitation
  • Type2 Diabetes
  • vitamin D
  • vitamin D placebo
  • (no location specified)
Jul 15, 2021

Hypercholesterolemia Trial (Atorvastatin, Ezetimibe, Ezetimibe/atorvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Immune Thrombocytopenic Purpura Trial in Sohag (Genotyping of rs1883832C/T related single-nucleotide polymorphism)

Not yet recruiting
  • Immune Thrombocytopenic Purpura
  • Genotyping of rs1883832C/T related single-nucleotide polymorphism
  • Sohag, Egypt
    Sohag University hospitals
Oct 16, 2022

Chronic Hepatitis C Trial in Hines (20mg ezetimibe, Placebo, 40mg ezetimibe)

Terminated
Has Results
  • Chronic Hepatitis C
  • 20mg ezetimibe
  • +2 more
  • Hines, Illinois
    Edward Hines Jr. VA Hospital, Hines, IL
May 10, 2022

Leg Ulcer Trial in London, Norwich (geko™ X-W3)

Not yet recruiting
  • Leg Ulcer
  • geko™ X-W3
  • London, United Kingdom
  • +1 more
Oct 10, 2023

Hypercholesterolemia Trial (ezetimibe (+) simvastatin, Comparator: atorvastatin, Comparator: rosuvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • ezetimibe (+) simvastatin
  • +2 more
  • (no location specified)
Feb 7, 2022

C.Delivery; Penetration, Pregnant Uterus, by Instrument, Obesity Trial in Phoenix, Aurora (Randomizing to Suture or Staple

Completed
  • C.Delivery; Penetration, Pregnant Uterus, by Instrument
  • Obesity
  • Randomizing to Suture or Staple closure of Cesarean section
  • Phoenix, Arizona
  • +1 more
Aug 24, 2022

Elevated Blood Lead Levels Trial in Mexico City (Lactobacillus plantarum DSM 33464, MegaMetalliQ, Placebo)

Not yet recruiting
  • Elevated Blood Lead Levels
  • Lactobacillus plantarum DSM 33464, MegaMetalliQ
  • Placebo
  • Mexico City, Mexico
    Universidad Iberoamericana A.C.
Aug 16, 2022

Platelet Aggregation, Type 2 Diabetes, Aspirin Trial in Montréal (Aspirin 81Mg Ec Tab twice daily for 7 days, Aspirin 40Mg Chew

Not yet recruiting
  • Platelet Aggregation
  • +4 more
  • Aspirin 81Mg Ec Tab twice daily for 7 days
  • +2 more
  • Montréal, Quebec, Canada
    Montreal Heart Institute
Jan 25, 2023

Glioma, Malignant Trial in Durham (D2C7-IT, 2141-V11)

Recruiting
  • Glioma, Malignant
  • Durham, North Carolina
    Duke University Medical Center
Jul 27, 2022

Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

Completed
  • Hepatitis C
  • Bradford, United Kingdom
  • +3 more
Jan 4, 2023

Hepatitis C, Liver Inflammation, Liver Cirrhoses Trial in Australia (Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet,

Recruiting
  • Hepatitis C
  • +2 more
  • Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
  • Sofosbuvir 400 MG + Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
  • Randwick, New South Wales, Australia
  • +6 more
Mar 28, 2022

Peritoneal Carcinomatosis Trial in Lexington (Mitomycin C, flat dose 40 mg, Mitomycin C, weight-based dose 12.5 mg/m2)

Recruiting
  • Peritoneal Carcinomatosis
  • Mitomycin C, flat dose 40 mg
  • Mitomycin C, weight-based dose 12.5 mg/m2
  • Lexington, Kentucky
    University of Kentucky
Mar 1, 2022

Healthy Adults Trial in Créteil (Solo 0.3 group, Solo 1 group, Solo 3 group)

Recruiting
  • Healthy Adults
  • Solo 0.3 group
  • +5 more
  • Créteil, France
  • +2 more
Sep 9, 2022

Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)

Completed
  • Relapsed or Refractory Lymphoma
  • Itraconazole 200 mg
  • +3 more
  • Miami, Florida
    QPS- Miami
Jan 12, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Gilteritinib 40 MG Oral Tablet
  • +4 more
  • Lexington, Kentucky
    University of Kentucky
Oct 27, 2022

Child Health Trial in Falun, Karlskrona, Kisa (Partnering for change (P4C-Swe), Treatment as usual)

Recruiting
  • Child Health
  • Partnering for change (P4C-Swe)
  • Treatment as usual
  • Falun, Sweden
  • +2 more
Jun 22, 2022

Common Cold, Acute Respiratory Infection, Influenza, Human Trial in Russian Federation (XC8, film-coated tablets, 10 mg,

Recruiting
  • Common Cold
  • +2 more
  • XC8, film-coated tablets, 10 mg
  • Placebo
  • Ivanovo, Russian Federation
  • +5 more
May 27, 2022